Health Canada has completed a review of safety information for Losec (omeprazole) and Nexium (esomeprazole) and found no increased cardiovascular risks.
Both prescription drugs are used to treat conditions in which a reduction of gastric acid secretion is required, such as ulcers and reflux.
In Canada, omeprazole is also sold in generic form as Apo-omeprazole, Ratio-omeprazole and Sandoz-omeprazole. Esomeprazole is only sold under the trade name Nexium.
Based on its review, Health Canada scientists said they found no evidence supporting an increased cardiovascular risk associated with the long-term use of either drug.
Officials advised patients taking either Losec or Nexium to not make any changes to their medication unless they first discuss it with their physicians.
Copyright 2008 by United Press International
Explore further: FDA: generic copaxone approved for multiple sclerosis